PubRank

Drakoulis Yannoukakos

Author PubWeight™ 51.71‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Breast-cancer risk in families with mutations in PALB2. N Engl J Med 2014 4.97
2 A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat Genet 2010 4.96
3 Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet 2013 4.35
4 A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat Genet 2011 3.37
5 Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. PLoS Genet 2013 2.39
6 Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. Am J Hum Genet 2013 2.24
7 19p13.1 is a triple-negative-specific breast cancer susceptibility locus. Cancer Res 2012 1.81
8 Common breast cancer susceptibility loci are associated with triple-negative breast cancer. Cancer Res 2011 1.65
9 Growth index is independent of microvessel density in non-small-cell lung carcinomas. Hum Pathol 2002 1.53
10 Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer. Carcinogenesis 2013 1.28
11 On the origin and diffusion of BRCA1 c.5266dupC (5382insC) in European populations. Eur J Hum Genet 2010 1.17
12 Prevalence of GJB2 mutations in prelingual deafness in the Greek population. Int J Pediatr Otorhinolaryngol 2002 1.06
13 Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study. Breast Cancer Res Treat 2012 1.01
14 A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium. Hum Mol Genet 2013 1.00
15 Collaborative genomics for human health and cooperation in the Mediterranean region. Nat Genet 2010 0.99
16 G1738R is a BRCA1 founder mutation in Greek breast/ovarian cancer patients: evaluation of its pathogenicity and inferences on its genealogical history. Breast Cancer Res Treat 2007 0.97
17 A newly detected mutation of the RET protooncogene in exon 8 as a cause of multiple endocrine neoplasia type 2A. Hormones (Athens) 2007 0.96
18 Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patients. Breast Cancer Res Treat 2007 0.94
19 Breast cancer risk in BRCA1 and BRCA2 mutation carriers and polyglutamine repeat length in the AIB1 gene. Int J Cancer 2005 0.91
20 International distribution and age estimation of the Portuguese BRCA2 c.156_157insAlu founder mutation. Breast Cancer Res Treat 2010 0.91
21 Novel genomic rearrangements in the BRCA1 gene detected in Greek breast/ovarian cancer patients. Eur J Cancer 2006 0.90
22 Characterization of a novel large deletion and single point mutations in the BRCA1 gene in a Greek cohort of families with suspected hereditary breast cancer. BMC Cancer 2004 0.88
23 Thermal unfolding of human BRCA1 BRCT-domain variants. Biochim Biophys Acta 2007 0.86
24 Common BRCA2 variants and modification of breast and ovarian cancer risk in BRCA1 mutation carriers. Cancer Epidemiol Biomarkers Prev 2005 0.86
25 BRCA2 gene mutations in Greek patients with familial breast cancer. Hum Mutat 2002 0.86
26 Evaluation of dHPLC in mutation screening of the APC gene in a Greek FAP cohort. Anticancer Res 2003 0.85
27 Mutational spectrum of APC and genotype-phenotype correlations in Greek FAP patients. BMC Cancer 2010 0.85
28 A distinct mutation on the alternative splice site of APC exon 9 results in attenuated familial adenomatous polyposis phenotype. Fam Cancer 2010 0.82
29 A rare RET gene exon 8 mutation is found in two Greek kindreds with familial medullary thyroid carcinoma: implications for screening. Clin Endocrinol (Oxf) 2006 0.80
30 Prevalence of BRCA1 mutations in familial and sporadic greek ovarian cancer cases. PLoS One 2013 0.80
31 BRCA1 wild-type allele modifies risk of ovarian cancer in carriers of BRCA1 germ-line mutations. Cancer Epidemiol Biomarkers Prev 2003 0.79
32 Thermodynamic study of the BRCT domain of BARD1 and its interaction with the -pSER-X-X-Phe- motif-containing BRIP1 peptide. Biochim Biophys Acta 2010 0.79
33 Fully integrated monolithic optoelectronic transducer for real-time protein and DNA detection: the NEMOSLAB approach. Biosens Bioelectron 2010 0.78
34 Hereditary cancer syndromes. J BUON 2007 0.78
35 Atypical medullary breast carcinoma in a family carrying the 5382insC BRCA-1 mutation. Breast J 2003 0.77
36 Screening of the DNA mismatch repair genes MLH1, MSH2 and MSH6 in a Greek cohort of Lynch syndrome suspected families. BMC Cancer 2010 0.77
37 Lack of association between RNASEL Arg462Gln variant and the risk of breast cancer. Anticancer Res 2004 0.77
38 Thermal denaturation of the BRCT tandem repeat region of human tumour suppressor gene product BRCA1. Biophys Chem 2004 0.76
39 A change in the last base of BRCA1 exon 23, 5586G-->A, results in abnormal RNA splicing. Cancer Genet Cytogenet 2002 0.75
40 An in-frame exon-skipping MUTYH mutation is associated with early-onset colorectal cancer. Dis Colon Rectum 2010 0.75
41 Culture of primary epithelial adenoma cells from familial adenomatous polyposis patients. Anticancer Res 2008 0.75